Phase IV clinical trial result of Shin Poong Pharm’s Pyramax announced at conference in Africa

Published: 2018-05-16 16:30:00
Updated: 2018-05-16 16:03:32

In the Satellite symposium at the Pan African Malaria Conference – Multilateral Initiatives on Malaria(MM) at Dakar, Senegal, Shin Poong Pharm(CEO Jae-Man Yoo) announced the Pyramax’s clinical trial result.

Held around African countries every 4 years, the MM is one of the largest symposiums in t...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.